Brp Group, Inc. BRP
We take great care to ensure that the data presented and summarized in this overview for BRP Group, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding BRP
View all-
Vanguard Group Inc Valley Forge, PA6.56MShares$263 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL5.4MShares$216 Million0.62% of portfolio
-
Black Rock Inc. New York, NY4.75MShares$190 Million0.0% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.51MShares$181 Million0.04% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT3.26MShares$130 Million0.96% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.24MShares$130 Million0.09% of portfolio
-
Capital International Investors Los Angeles, CA3.15MShares$126 Million0.02% of portfolio
-
Bamco Inc New York, NY3.01MShares$120 Million0.34% of portfolio
-
Macquarie Group LTD Australia, C32.53MShares$101 Million0.13% of portfolio
-
State Street Corp Boston, MA2.08MShares$83.5 Million0.0% of portfolio
Latest Institutional Activity in BRP
Top Purchases
Top Sells
About BRP
BRP Group, Inc. markets and sells insurance products and services in the United States. The company operates through four segments: Middle Market, Specialty, MainStreet, and Medicare. The Middle Market segment provides commercial risk management, employee benefits solutions, and private risk management for mid-to-large size businesses and high net worth individuals, as well as its families. The Specialty segment delivers specialty insurers, professionals, individuals, and industry businesses the access to specialty markets, as well as capabilities and programs requiring underwriting and placement. This segment also operates as a managing general agent of the Future platform, which delivers proprietary, technology-enabled insurance solutions. The MainStreet segment offers personal insurance, commercial insurance, and life and health solutions to individuals and businesses in its communities. The Medicare segment provides consultation for government assistance programs and solutions, including Medicare and Medicare Advantage to seniors and Medicare-eligible individuals through a network of primarily independent contractor agents. The company was founded in 2011 and is headquartered in Tampa, Florida.
Insider Transactions at BRP
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 01
2025
|
Barbara Ruth Matas Director |
BUY
Grant, award, or other acquisition
|
Direct |
861
+5.07%
|
-
|
|
Oct 01
2025
|
Joseph John Kadow Director |
BUY
Grant, award, or other acquisition
|
Direct |
861
+5.07%
|
-
|
|
Oct 01
2025
|
Jay A Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
861
+5.38%
|
-
|
|
Oct 01
2025
|
Chris Thomas Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
861
+1.04%
|
-
|
|
Oct 01
2025
|
Ellyn Shook Director |
BUY
Grant, award, or other acquisition
|
Direct |
861
+7.28%
|
-
|
|
Oct 01
2025
|
Sunita Parasuraman Director |
BUY
Grant, award, or other acquisition
|
Direct |
861
+7.28%
|
-
|
|
Oct 01
2025
|
Sathish Muthukrishnan Director |
BUY
Grant, award, or other acquisition
|
Direct |
861
+11.28%
|
-
|
|
Oct 01
2025
|
Myron K Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
861
+7.28%
|
-
|
|
Aug 13
2025
|
Seth Bala Cohen General Counsel |
SELL
Open market or private sale
|
Direct |
2,775
-20.96%
|
$94,350
$34.0 P/Share
|
|
Aug 07
2025
|
Bradford Hale Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+6.47%
|
$280,000
$28.72 P/Share
|
|
Jul 01
2025
|
Myron K Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
645
+6.0%
|
-
|
|
Jul 01
2025
|
Jay A Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
645
+4.32%
|
-
|
|
Jul 01
2025
|
Sathish Muthukrishnan Director |
BUY
Grant, award, or other acquisition
|
Direct |
645
+9.84%
|
-
|
|
Jul 01
2025
|
Sunita Parasuraman Director |
BUY
Grant, award, or other acquisition
|
Direct |
645
+6.0%
|
-
|
|
Jul 01
2025
|
Ellyn Shook Director |
BUY
Grant, award, or other acquisition
|
Direct |
645
+6.0%
|
-
|
|
Jul 01
2025
|
Chris Thomas Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
645
+0.79%
|
-
|
|
Jul 01
2025
|
Joseph John Kadow Director |
BUY
Grant, award, or other acquisition
|
Direct |
645
+4.06%
|
-
|
|
Jul 01
2025
|
Barbara Ruth Matas Director |
BUY
Grant, award, or other acquisition
|
Direct |
645
+4.06%
|
-
|
|
Jun 13
2025
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
26,679
-38.78%
|
$1,067,160
$40.07 P/Share
|
|
Jun 12
2025
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
10,894
-13.67%
|
$435,760
$40.03 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 374K shares |
|---|---|
| Conversion of derivative security | 899K shares |
| Other acquisition or disposition | 300K shares |
| Open market or private purchase | 10K shares |
| Conversion of derivative security | 899K shares |
|---|---|
| Other acquisition or disposition | 810K shares |
| Open market or private sale | 1.19M shares |
| Bona fide gift | 4.25K shares |
| Payment of exercise price or tax liability | 137K shares |